NCT04590196View on ClinicalTrials.gov

Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions
Age Related Macular Degeneration
Interventions
DRUG

Longvida curcumin

longvida curcumin verdure sciences formulation

OTHER

placebo

"Composition of Placebo :~95.66% Maltodextrin 0.34% Sunset Yellow Color 0.06% Tartrazine Food Color 3.91% Silicon Dioxide"

Trial Locations (1)

60612

Illinois eye and ear infirmary, Chicago

All Listed Sponsors
collaborator

VitreoRetinal Surgery Foundation

UNKNOWN

collaborator

Illinois Society for the Prevention of Blindness

UNKNOWN

lead

University of Illinois at Chicago

OTHER

NCT04590196 - Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients | Biotech Hunter | Biotech Hunter